Baby hospitalizations from RSV fell up to 71% with new vaccine, treatment

Baby hospitalizations from RSV fell up to 71% with new vaccine, treatment

CDC study finds big declines in hospitalizations—and they may be underestimates.

RSV sent fewer babies to the hospital last winter, after new treatment and vaccine arrived

This was the first winter in which the Abrysvo vaccine and Beyfortus RSV antibody were available to protect babies from the virus.

The antibody was given to newborns and babies under three months of age starting in autumn 2024. Taking the antibody was voluntary.

New RSV vaccine, treatment linked to dramatic fall in baby hospitalizations

Far fewer babies went to the hospital struggling to breathe from RSV, a severe respiratory infection, after the debut of a new vaccine and treatment this season, according to an analysis published today by the Centers for Disease Control and Prevention. RSV, or respiratory syncytial (sin-SISH-uhl) virus, is the leading cause of hospitalization for infants in the US. An estimated 58,000–80,000 children younger than 5 years old are hospitalized ea…